Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

HBV Prevention in Foreign-Born Women

Clin Infect Dis; ePub 2018 Jun 1; Kilmer, et al

Foreign-born women of reproductive age living in the US have lower hepatitis B virus (HBV) vaccination and screening coverage than their US-born counterparts and screening for HBV is underutilized, a recent report suggests. Researchers pooled data from the National Health Interview Survey 2013-2015 to estimated prevalence of lifetime history of HBV vaccination and screening self-reported to women aged 18 to 44 years who were born in the US or elsewhere. They found:

  • Among women of reproductive age (n=24,216), reported HBV vaccination was 33% lower for foreign-born (27.3%) than US-born (40.9%) women.
  • Vaccination coverage was low for women born in Mexico and other parts of Central America.
  • Factors association with vaccination in both groups included education, income, and health insurance coverage.
  • Screening was reported by 28.5% of foreign-born vs 31.9% of US-born women.

Citation:

Kilmer GA, Barker LK, Ly KN, Jiles RB. Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015. [Published online ahead of print June 1, 2018]. Clin Infect Dis. doi:10.1093/cid/ciy479.

This Week's Must Reads

Difficult-to-Treat Resistance in GNBSIs, Clin Infect Dis; ePub 2018 Jul 23; Kadri, et al

Missed Opportunities for HIV Testing, Open Forum Infect Dis; ePub 2018 Jul 19; Kapadia, et al

Bacterial STI Screening Rates Among MSM, Sex Transm Dis; ePub 2018 Jul 24; Jenness, et al

Patient Engagement in HIV Care, AIDS; ePub 2018 Jul 12; Lee, Wu, et al

IDSA/ASM Lab Guide for Diagnosis of IDs, Clin Infect Dis; ePub 2018 Jun 28; Miller, et al

Must Reads in Hepatitis

Pregnancy Outcomes in Women with HBV , Open Forum Infect Dis; ePub 2018 Jun 9; Bajema, et al

HBV Prevention in Foreign-Born Women, Clin Infect Dis; ePub 2018 Jun 1; Kilmer, et al

ACIP Recommends Hepatitis B Vaccine for Adults, MMWR; 2018 Apr 20; Schillie, Harris, et al

HCV Treatment as Prevention in PWIDs, Lancet; 2018 Feb; Zelenev, Li, et al

Microbial Translocation & Immune Activation in HIV and HCV, J Infect Dis; ePub 2018 Jan 3; Reid, Ma, et al